Loss or reduction of expression and function of potassium channels has been shown to be involved in the pathobiology of PAH, and restoration of these channels ameliorated or reversed PAH in experimental models [58,59]. The gene discussed is KCNA3; the disease is pulmonary arterial hypertension.